Bisphosphonates, phossy jaw, and bisphosphonate-related osteonecrosis of the jaw

J Okla Dent Assoc. 2011 Jul-Aug;102(5):36-9.
No abstract available

MeSH terms

  • Adenosine Triphosphate / metabolism
  • Administration, Oral
  • Apoptosis
  • Binding, Competitive
  • Bone Density Conservation Agents / administration & dosage
  • Bone Density Conservation Agents / adverse effects*
  • Bone Density Conservation Agents / chemistry
  • Bone Density Conservation Agents / pharmacokinetics
  • Diphosphonates / administration & dosage
  • Diphosphonates / adverse effects*
  • Diphosphonates / chemistry
  • Diphosphonates / pharmacokinetics
  • Geranyltranstransferase / metabolism
  • Humans
  • Injections, Intravenous
  • Jaw Diseases / chemically induced*
  • Jaw Diseases / pathology
  • Jaw Diseases / therapy
  • Middle Aged
  • Nitrogen / metabolism
  • Osteoclasts / metabolism
  • Osteonecrosis / chemically induced*
  • Osteonecrosis / pathology
  • Osteonecrosis / therapy
  • Osteoporosis / drug therapy
  • Phosphorus / adverse effects

Substances

  • Bone Density Conservation Agents
  • Diphosphonates
  • Phosphorus
  • Adenosine Triphosphate
  • Geranyltranstransferase
  • Nitrogen